Cisplatin combined with the new cisplatin-procaine complex dpr: In vitro and in vivo studies
- 作者M. Viale; M.O. Vannozzi; F. Merlo; S. Cafaggi; B. Parodi; M. Esposito
- 卷第32卷
- 期第13期
- 印刷ISSN0959-8049
- 文件大小741.17KB
- 发表时间1996
- DOI10.1016/s0959-8049(96)00354-1
Amifostine (Ethyol®): Dosing, administration and patient management guidelinesR.M. Bukowski · 1996
Combination chemotherapy including VP-16 for poor prognosis germ cell neoplasmsR.M. Bukowski; G.W. Smith; J.E. Montie · 1988
Clinical effects of amifostine (Ethyol®) in patients treated with carboplatinG.T. Budd; R. Ganapathi; R.M. Bukowski; S. Murthy · 1996
Immunologic Changes in Renal Cell Carcinoma Patients Receiving Gamma InterferonBarna, B.P.; Thomassen, M.J.; Sergi, J.; Murthy, S.; Bukowski, R.M. · Oncology · 1991
Mixed beam radiotherapy and combination chemotherapy in localized pancreatic adenocarcinoma—Preliminary resultsR.M. Bukowski; Reinhard Gahbauer; Antonio Rodriquez-Antunez; Robert Hermann · 1982
Current Approaches in Cytoprotection: the Role of Amifostine (Ethyol®) in Altering and Ameliorating Toxicities in Cancer TherapyR.M. Bukowski · 1996
A Phase I Trial of Weekly Gemcitabine and Subcutaneous Interferon Alpha in Patients with Refractory Renal Cell CarcinomaF. Perez-Zincer; T. Olencki; G.T. Budd; D. Peereboom; P. Elson; R.M. Bukowski · 2002